-
1
-
-
77953801701
-
Review article: Malignancy on thiopurine treatment with special reference to inflammatory bowel disease
-
Smith MA, Irving PM, Marinaki AM, et al. Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease. Aliment Pharmacol Ther 2010;32:119-130.
-
(2010)
Aliment Pharmacol Ther
, vol.32
, pp. 119-130
-
-
Smith, M.A.1
Irving, P.M.2
Marinaki, A.M.3
-
2
-
-
70449100743
-
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study
-
Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009;374:1617-1625.
-
(2009)
Lancet
, vol.374
, pp. 1617-1625
-
-
Beaugerie, L.1
Brousse, N.2
Bouvier, A.M.3
-
3
-
-
77954426838
-
Risk of cancer in inflammatory bowel disease treated with azathioprine: A UK population-based case-control study
-
Armstrong RG, West J, Card TR. Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Am J Gastroenterol 2010;105:1604-1609.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 1604-1609
-
-
Armstrong, R.G.1
West, J.2
Card, T.R.3
-
4
-
-
22644446331
-
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
-
Kandiel A, Fraser AG, Korelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005;54:1121-1125.
-
(2005)
Gut
, vol.54
, pp. 1121-1125
-
-
Kandiel, A.1
Fraser, A.G.2
Korelitz, B.I.3
-
5
-
-
79955818117
-
Nonmelanoma skin cancer in inflammatory bowel disease: A review
-
Long MD, Kappelman MD, Pipkin CA. Nonmelanoma skin cancer in inflammatory bowel disease: a review. Inflamm Bowel Dis 2011;17:1423-1427.
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 1423-1427
-
-
Long, M.D.1
Kappelman, M.D.2
Pipkin, C.A.3
-
6
-
-
77349117814
-
Increased risk for nonmelanoma skin cancer in patients with inflammatory bowel disease
-
Long MD, Herfarth HH, Pipkin CA, et al. Increased risk for nonmelanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2010;8:268-274.
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 268-274
-
-
Long, M.D.1
Herfarth, H.H.2
Pipkin, C.A.3
-
7
-
-
79955025395
-
Risk of non-melanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased
-
van Schaik FD, van Oijen MG, Smeets HM, et al. Risk of non-melanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased. Clin Gastroenterol Hepatol 2011;9:449-450.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 449-450
-
-
Van Schaik, F.D.1
Van Oijen, M.G.2
Smeets, H.M.3
-
8
-
-
80054862378
-
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease
-
Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 2011;141:1621-1628.
-
(2011)
Gastroenterology
, vol.141
, pp. 1621-1628
-
-
Peyrin-Biroulet, L.1
Khosrotehrani, K.2
Carrat, F.3
-
9
-
-
0037464506
-
Skin cancers after organ transplantation
-
Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-1691.
-
(2003)
N Engl J Med
, vol.348
, pp. 1681-1691
-
-
Euvrard, S.1
Kanitakis, J.2
Claudy, A.3
-
10
-
-
0033795921
-
Incidence of skin cancer in 5356 patients following organ transplantation
-
Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-519.
-
(2000)
Br J Dermatol
, vol.143
, pp. 513-519
-
-
Lindelof, B.1
Sigurgeirsson, B.2
Gabel, H.3
-
11
-
-
0033007170
-
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
-
Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177-186.
-
(1999)
J Am Acad Dermatol
, vol.40
, pp. 177-186
-
-
Jensen, P.1
Hansen, S.2
Moller, B.3
-
12
-
-
24944519200
-
Azathioprine and UVA light generate mutagenic oxidative DNA damage
-
O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005;309:1871-1874.
-
(2005)
Science
, vol.309
, pp. 1871-1874
-
-
O'Donovan, P.1
Perrett, C.M.2
Zhang, X.3
-
13
-
-
77954426269
-
Risk of extra-intestinal cancer in inflammatory bowel disease: Meta-analysis of population-based cohort studies
-
Pedersen N, Duricova D, Elkjaer M, et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol 2010;105:1480-1487.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 1480-1487
-
-
Pedersen, N.1
Duricova, D.2
Elkjaer, M.3
-
14
-
-
80054865266
-
Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease
-
Singh H, Nugent Z, Demers AA, et al. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. Gastroenterology 2011;141:1612-1620.
-
(2011)
Gastroenterology
, vol.141
, pp. 1612-1620
-
-
Singh, H.1
Nugent, Z.2
Demers, A.A.3
|